OrbiMed portfolio

OrbiMed (Venture capital) is known to hold 198 companies, 72 of them startups. 39 of them are hiring now, with 248 open roles. Its companies closed 14 venture rounds in 12 months, raising $1.2B. Most of them work in Drug Discovery, Biologics & Biosimilars, Oncology Therapeutics.

Source: Alion Venture capital Oct 3, 2026
Investments
198
72 of them startups
Hiring now
39
248 open roles
Rounds in 12 months
14
$1.2B raised
Exits
48

Companies OrbiMed has invested in

Altis Labs Series A $25M · this month 6 roles portfolio pageSep 25
TytoCare Israel Venture round $25M · 2 mo ago portfolio pageSep 25
Fore Biotherapeutics Series D $67.4M · 2 mo ago portfolio pageSep 25
Triveni Bio Biologics & Biosimilars Series C $65M · 3 mo ago portfolio pageSep 25
TruNativ Series B $30M · 3 mo ago portfolio pageSep 25
Vivacta bio Series A · 5 mo ago portfolio pageSep 25
Sidewinder Therapeutics Biologics & Biosimilars Series B $137M · 5 mo ago portfolio pageSep 25
Stairmed Venture round $500M · 6 mo ago portfolio pageSep 25
Congruence Venture round $39.5M · 6 mo ago portfolio pageSep 25
One moment, please... Venture round $32.8M · 7 mo ago portfolio pageSep 25
QuantX Biosciences Series B $85M · 7 mo ago portfolio pageSep 25
Thlsq Video Surveillance · Israel Venture round $3.3M · 8 mo ago portfolio pageSep 25
TandemAI Drug Discovery Series A $22M · 10 mo ago portfolio pageSep 25
Braveheart Venture round $185M · 10 mo ago portfolio pageSep 25
STAR Therapeutics Series D $125M · 12 mo ago portfolio pageSep 25
Avenzo Therapeutics Series B $60M · 12 mo ago 5 roles portfolio pageSep 25
Charm Therapeutics United Kingdom Series B $80M · 13 mo ago portfolio pageSep 25
Treeline Biosciences United States Venture round $200.1M · 13 mo ago 10 roles portfolio pageSep 25
Inspiremd Venture round $40.1M · 14 mo ago portfolio pageSep 25
vVARDIS Switzerland Venture round $50M · 14 mo ago portfolio pageSep 25
RenasantBio United States Venture round $30M · 15 mo ago portfolio pageSep 25
Alpheus Medical Oncology Therapeutics · United States Series B $52M · 16 mo ago portfolio pageSep 25
AER Therapeutics United States Venture round $5M · 20 mo ago portfolio pageSep 25
Windward Bio Drug Discovery Series A $200M · 20 mo ago lead portfolio page, round in the pressJan 13, 2025
Verdiva Bio Cardiometabolic Therapeutics Series A $410M · 20 mo ago portfolio pageSep 25
Aerinmedical Venture round $32.5M · 21 mo ago portfolio pageSep 25
Alentis Therapeutics Biologics & Biosimilars Series D $181.4M · 22 mo ago lead portfolio page, round in the pressNov 12, 2024
Iambic Therapeutics Drug Discovery AI · United States Convertible Note $75k · 2 yr ago portfolio pageSep 25
Pathalys Pharma, Inc. Biologics & Biosimilars Series B $105M · 2 yr ago portfolio pageSep 25
Brenig Therapeutics, Inc. Neurology & CNS Therapeutics Series A $65M · 2 yr ago portfolio pageSep 25
Alumis Prescription Drugs · United States Venture round $40M · 2 yr ago 1 role portfolio pageSep 25
Traws Pharma United States Venture round $14M · 2 yr ago portfolio pageSep 25
Enliven Therapeutics Drug Discovery · United States Venture round $90M · 2 yr ago portfolio pageSep 25
Vanqua Bio Neurology & CNS Therapeutics · United States Venture round $45M · 2 yr ago portfolio pageSep 25
BioAge Labs Fitness · United States Venture round $194.4M · 2 yr ago 2 roles portfolio pageSep 25
Forward Therapeutics Venture round $50M · 2 yr ago portfolio pageSep 25
Evozyne United States Series B $81M · 3 yr ago portfolio pageSep 25
Corteria Series A $70.7M · 3 yr ago lead portfolio page, round in the pressSep 6, 2023
ImageneBio Immunology & Inflammation Therapeutics · United States Venture round $42.6M · 3 yr ago portfolio pageSep 25
Createrna Series A · 3 yr ago portfolio pageSep 25
mdxhealth Diagnostic Tests & IVD · Belgium Venture round $5M · 4 yr ago 2 roles portfolio pageSep 25
DELFI Diagnostics Precision Medicine · United States Venture round $225M · 4 yr ago 5 roles portfolio pageSep 25
GentiBio Cell & Gene Therapy Series A $157M · 5 yr ago portfolio pageSep 25
Kumquat Biosciences Oncology Therapeutics · United States Venture round $30M · 5 yr ago portfolio pageSep 25
Neurogastrx United States Venture round $60M · 5 yr ago portfolio pageSep 25
Pee Safe Personal Care Venture round $3M · 5 yr ago portfolio pageSep 25
Pathai Medical AI Series C $165M · 5 yr ago 1 role portfolio pageSep 25
Neurelis Prescription Drugs · United States Venture round $114.8M · 5 yr ago 3 roles portfolio pageSep 25
Variantyx - Genomics & Genetic Testing · United States Venture round $15.6M · 5 yr ago portfolio pageSep 25
Propeller Venture round $864k · 5 yr ago portfolio pageSep 25
Noctrix Health Neurotech & Neuromodulation · United States Venture round $16.9M · 5 yr ago 15 roles portfolio pageSep 25
Perfuse Therapeutics United States Venture round $9M · 6 yr ago portfolio pageSep 25
Compass Therapeutics Venture round $60.5M · 6 yr ago 3 roles portfolio pageSep 25
Shattuck Labs United States Venture round $83M · 6 yr ago 1 role portfolio pageSep 25
Helicore Biopharma Venture round $2M · 6 yr ago portfolio pageSep 25
Avitide Venture round $10M · 6 yr ago portfolio pageSep 25
Telabio Venture round $10.6M · 7 yr ago portfolio pageSep 25
acutusmedical.com Venture round $136.7M · 7 yr ago portfolio pageSep 25
memebox Brewing & Beer Venture round $35M · 7 yr ago portfolio pageSep 25
Emergent BioSolutions Public Health & Prevention · United States Venture round $47.9M · 7 yr ago 15 roles portfolio pageSep 25
Netmeds Pharmacies · India Venture round $35M · 8 yr ago lead round in the pressOct 26, 2015
Sikka Software Corporation Autonomous Driving Series C $10.5M · 11 yr ago portfolio pageSep 25
Starling Oncology Cancer Care Centers · United States 28 roles portfolio pageSep 25
Myriad Genetics Genomics & Genetic Testing · United States 20 roles portfolio pageSep 25
Disc Medicine United States 12 roles portfolio pageSep 25
NeuroPace Neurotech & Neuromodulation · United States 11 roles portfolio pageSep 25
Velsera Precision Medicine 8 roles portfolio pageSep 25
Carrot Fertility Health Insurance & Benefits 7 roles portfolio pageSep 25
Janux Therapeutics | Novel T Cell Immunotherapies Biologics & Biosimilars · United States 7 roles portfolio pageSep 25
Adicet Bio Cell & Gene Therapy · United States 5 roles portfolio pageSep 25
Intelliatx Cell & Gene Therapy 5 roles portfolio pageSep 25
MDClone Health Data & Interoperability · Israel 3 roles portfolio pageSep 25
bhtherapeutics Oncology Therapeutics 2 roles portfolio pageSep 25
Lexeo Therapeutics Prescription Drugs · United States 2 roles portfolio pageSep 25
Alterome Precision Medicine 1 role portfolio pageSep 25
Crinetics Prescription Drugs · United States 1 role portfolio pageSep 25
Prelude Therapeutics Oncology Therapeutics 1 role portfolio pageSep 25
Radius Health, Inc. Prescription Drugs · United States 1 role portfolio pageSep 25
Tigerconnect Patient Access & Booking 1 role portfolio pageSep 25
Adcendo Biologics & Biosimilars portfolio pageSep 25
ADELA Medical Laboratories portfolio pageSep 25
Advanced Enzymes Animal Nutrition portfolio pageSep 25
AirNexis Respiratory & Sleep Devices portfolio pageSep 25
AirStrip® Predictive Analytics portfolio pageSep 25
Angitia Biopharmaceuticals Biologics & Biosimilars portfolio pageSep 25
12

Focus

Markets
Drug Discovery7%
Biologics & Biosimilars4%
Oncology Therapeutics4%
Cell & Gene Therapy4%
Prescription Drugs4%
Precision Medicine3%
Immunology & Inflammation Therapeutics3%
Vaccines3%
Where its companies are
United States17%
Israel2%
United Kingdom1%
Belgium1%
Switzerland1%
Hong Kong1%
India1%
Stage of its companies
Venture, series not stated63%
Series A15%
Series B13%
Series C and later10%

Questions about OrbiMed

How many companies has OrbiMed invested in?

OrbiMed is known to hold 198 companies: 72 startups, and 48 exits so far, read from its own portfolio page and the funding rounds that name it.

Is OrbiMed investing now?

OrbiMed has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does OrbiMed invest in?

The markets of the companies OrbiMed holds: Drug Discovery (7%), Biologics & Biosimilars (4%), Oncology Therapeutics (4%), Cell & Gene Therapy (4%), Prescription Drugs (4%).

Which OrbiMed portfolio companies are hiring?

39 companies OrbiMed holds are hiring now, with 248 open roles listed on this page.

Who does OrbiMed invest alongside?

The investors that hold the most companies together with OrbiMed: RA Capital Management, Foresite Capital, SR One, Wellington Management, Atlas Venture.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 3; 4 rounds in the press that name it

OrbiMed portfolio: 198 known companies. Alion, Oct 3, 2026. https://alion.io/company/orbimed/portfolio

Licence: CC BY-SA 4.0JSON